Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2010 4
2011 3
2012 2
2013 5
2014 3
2015 3
2016 6
2017 3
2018 6
2019 5
2020 4
2021 4
2022 8
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R. Lindberg K, et al. Among authors: persson gf. J Thorac Oncol. 2021 Jul;16(7):1200-1210. doi: 10.1016/j.jtho.2021.03.019. Epub 2021 Apr 3. J Thorac Oncol. 2021. PMID: 33823286 Free article. Clinical Trial.
The role of image guidance in respiratory gated radiotherapy.
Korreman SS, Juhler-Nøttrup T, Persson GF, Navrsted Pedersen A, Enmark M, Nystrom H, Specht L. Korreman SS, et al. Among authors: persson gf. Acta Oncol. 2008;47(7):1390-6. doi: 10.1080/02841860802282786. Acta Oncol. 2008. PMID: 18622771 Review.
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindbäck E, Jirf KA, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Møller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Hagen RK, Frøland AS, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R, Lindberg K. Lindberg S, et al. Among authors: persson gf. Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1222-1231. doi: 10.1016/j.ijrobp.2023.06.246. Epub 2023 Jul 8. Int J Radiat Oncol Biol Phys. 2023. PMID: 37423292
Patterns of care in oligometastatic disease: the clinicians' perspective.
Felter MVO, Josipovic M, Serup-Hansen E, Geertsen PF, Behrens CF, Khalil AA, Persson GF. Felter MVO, et al. Among authors: persson gf. Acta Oncol. 2022 Sep;61(9):1148-1151. doi: 10.1080/0284186X.2022.2114380. Epub 2022 Aug 25. Acta Oncol. 2022. PMID: 36017569 No abstract available.
Real-world data on melanoma brain metastases and survival outcome.
Pedersen S, Møller S, Donia M, Persson GF, Svane IM, Ellebaek E. Pedersen S, et al. Among authors: persson gf. Melanoma Res. 2022 Jun 1;32(3):173-182. doi: 10.1097/CMR.0000000000000816. Epub 2022 Mar 7. Melanoma Res. 2022. PMID: 35256571
Metal artefact reduction for accurate tumour delineation in radiotherapy.
Kovacs DG, Rechner LA, Appelt AL, Berthelsen AK, Costa JC, Friborg J, Persson GF, Bangsgaard JP, Specht L, Aznar MC. Kovacs DG, et al. Among authors: persson gf. Radiother Oncol. 2018 Mar;126(3):479-486. doi: 10.1016/j.radonc.2017.09.029. Epub 2017 Oct 16. Radiother Oncol. 2018. PMID: 29050958 Free PMC article.
Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy.
Nielsen AM, Storm KS, Laursen MRT, Gram VR, Rechner LA, Ottosson W, Suppli MH, Sibolt P, Behrens CF, Vogelius IR, Persson GF. Nielsen AM, et al. Among authors: persson gf. Acta Oncol. 2023 Nov;62(11):1496-1501. doi: 10.1080/0284186X.2023.2251083. Epub 2023 Aug 30. Acta Oncol. 2023. PMID: 37647380 Clinical Trial.
60 results